About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Biosimilars User Fee Act (BsUFA) provides the FDA supplemental resources and staffing to support greater consistency and predictability in the regulatory review of biosimilar and interchangeable biosimilar products. Since enactment in 2012, BsUFA has played an essential role in strengthening the FDA’s ability to implement a regulatory approach for biosimilars that is consistent with the agency’s gold standard science-based review.